Skip Ribbon Commands
Skip to main content
News : Recent Press Releases     Op-Ed     Publications     About the Legislative Press Bureau Printer Friendly View
5/23/2019 House passes McNamara legislation to create link to ClinicalTrials.gov on Health Department website
STATE HOUSE — The House of Representatives has passed legislation sponsored by Rep. Joseph M. McNamara (D-Dist. 19, Warwick, Cranston) promoting the website ClinicalTrials.gov.

The bill (2019-H 5540A) would require the state Department of Health to post and maintain on its website a link to ClinicalTrials.gov, a free service of the National Institutes of Health Library of Medicine.

“Time is of the essence when individuals receive a diagnosis,” said Representative McNamara, who chairs the House Health, Education and Welfare Committee. “This bill will help people immediately access clinical trials that are available here in Rhode Island; and with many diseases, such as pancreatic cancer, having access to these trials can make a huge difference.”

ClinicalTrials.gov is a web-based resource that provides patients, their family members, health care professionals, researchers, and the public with easy access to information on publicly and privately supported clinical studies on a wide range of diseases and conditions. Information on ClinicalTrials.gov is provided and updated by the sponsor or principal investigator of the clinical study. Studies are generally submitted to the Web site when they begin, and the information on the site is updated throughout the study. In some cases, results of the study are submitted after the study ends. This website and database of clinical studies is commonly referred to as a "registry and results database."

A clinical trial is a research study in which human volunteers are assigned to interventions such as a medical product, behavior, or procedure based on a protocol and are then evaluated for effects on biomedical or health outcomes. ClinicalTrials.gov also contains records describing observational studies and programs providing access to investigational drugs outside of clinical trials.

The measure now moves to the Senate for consideration.



For more information, contact:
Daniel Trafford, Publicist
State House Room 20
Providence, RI 02903
(401)222-1922